Representation of Life Sciences Company Fagron Holding USA LLC

We served as lead counsel representing a national pharmaceutical ingredient supplier and its wholly-owned subsidiaries in an investigation of alleged False Claims Act (FCA) violations concerning inflated Average Wholesale Prices, kickbacks to physicians, and waivers of co-pays.  After a several-year investigation based on the filing of four separate qui tams, we negotiated a successful resolution of the litigation that was far less than the government’s alleged damages of several hundred million dollars. Reported decision: U.S. ex rel. Hueseman v. PSI et al., (WDTX) and U.S. ex rel. Sten v. Midwest Compounders, et al., (NDIA). 

You Also May Be Interested In:

  • Lead counsel to West Tennessee Healthcare in obtaining a Certificate of Need (CON) to convert its existing hospital-based outpatient surgery center to a freestanding multi-specialty surgery center that will provide state-of-the art services

    Bass Berry & Sims served as lead counsel to West Tennessee Healthcare in obtaining a Certificate of Need (CON) to...
    Client Type: Private Company
  • Lead counsel to a Memphis-based children’s research hospital in obtaining a Certificate of Need (CON) to initiate home health services

    Bass Berry & Sims served as lead counsel to a Memphis-based children's research hospital in obtaining a Certificate of Need...
    Client Type: Private Company
  • Lead counsel to Acadia Healthcare Company, Inc. in its efforts to obtain a Certificate of Need (CON) to open a state-of-the-art opioid treatment program (OTP) facility in suburban Nashville, Tennessee

    Bass, Berry & Sims served as lead counsel to Acadia Healthcare Company, Inc. in its efforts to obtain a Certificate...
    Client Type: Public Company